GHB and Alcohol: Why This Combination Kills

GHB (also called G, liquid G, or liquid ecstasy) and alcohol is one of the most dangerous drug combinations you can take at a rave, not because either substance alone is unusually lethal at common doses, but because the two interact synergistically to produce CNS and respiratory depression that is greater than the sum of its parts. A 2023 pharmacological review (PMID 36837798) concluded that while their pharmacokinetic interaction is modest, their combined toxicodynamic effect is substantial and clinically significant. People die from this combination at doses that would be survivable on their own.

Quick answers

Is GHB and alcohol dangerous? Yes, it is classified as a dangerous interaction by TripSit. The two substances potentiate each other’s CNS depressant effects and can produce unconsciousness and respiratory failure at doses that neither would cause alone.

Why does GHB and alcohol cause overdose? GHB and alcohol act on overlapping but distinct GABA receptor pathways. GHB is primarily a GABA-B agonist; alcohol primarily potentiates GABA-A receptors. Activating both simultaneously produces deeper CNS and respiratory depression than either drug achieves alone, the effect is synergistic, not merely additive.

What are the signs of GHB overdose? Sudden loss of consciousness, inability to be roused, vomiting while unconscious, labored or absent breathing, blue-tinged lips (cyanosis), seizures. The transition from conscious to unresponsive can happen in minutes.

What should I do if someone overdoses on GHB? Call emergency services immediately. Place the person in the recovery position (on their side) to reduce aspiration risk if they vomit. Do not leave them alone. Do not give them stimulants. Monitor breathing until help arrives.

Can you drink on GHB at all? There is no documented safe threshold for combining GHB with alcohol. Even moderate alcohol intake alongside a normal recreational GHB dose can trigger the overdose response.

How GHB works: a narrow therapeutic window

GHB (gamma-hydroxybutyrate) is a short-acting CNS depressant with a steep dose-response curve and an extremely narrow therapeutic window. At low doses (roughly 1–2 g), it produces euphoria and disinhibition. At moderate doses (2.5–3.5 g), sedation. At doses only modestly higher, as little as 3–4 g in a non-tolerant person, it can cause coma and life-threatening respiratory depression (PMID 26074743).

The margin between “a good time” and unconscious is approximately 2–3x the recreational dose. Alcohol, by comparison, has a safety ratio closer to 10x. GHB’s safety margin is among the narrowest of any recreational drug.

GHB acts primarily as a GABA-B receptor agonist at recreational concentrations, which inhibits neural excitability and slows CNS activity broadly, including respiratory drive. It also binds specific GHB receptors at lower concentrations, producing the euphoric component. The GABA-B activation is responsible for the sedative, amnesic, and respiratory depressant effects.

Pharmacokinetics are also a problem. GHB is absorbed quickly (peak plasma levels at 20–40 minutes), and at lower doses its elimination half-life is roughly 30–50 minutes. But metabolism is capacity-limited: at higher doses, elimination kinetics slow down and become nonlinear, meaning GHB can accumulate faster than expected (PMID 26074743). Alcohol co-ingestion extended GHB’s elimination half-life by approximately 29% in human pharmacokinetic studies, though this finding did not reach statistical significance (PMID 36837798).

How alcohol works and why it stacks dangerously with GHB

Alcohol (ethanol) is a CNS depressant that primarily works by potentiating GABA-A receptor activity: enhancing inhibitory neurotransmission throughout the brain, while also blocking NMDA glutamate receptors. Like GHB, it slows respiration, reduces consciousness, impairs coordination, and suppresses the gag reflex.

The key pharmacological point: GHB and alcohol do not cancel each other out or compete for the same receptor, they hit overlapping pathways through distinct mechanisms. GABA-B activation (GHB) and GABA-A potentiation (alcohol) produce additive and, at higher doses, synergistic depression of the same downstream outcomes: reduced respiratory rate, reduced consciousness, cardiovascular depression.

A controlled human study (16 healthy adults, double-blind crossover design) found that GHB + alcohol together caused six vomiting episodes and two hypotensive episodes (systolic BP dropping to 71–73 mmHg), as well as a measurable decrease in oxygen saturation beyond either drug alone. The conclusion: the pharmacodynamic interaction is real and clinically significant even at moderate, controlled doses (PMID 16974199).

Animal studies using co-administration of GBL (a GHB prodrug) and ethanol showed sleep times of 66 minutes for GBL alone, 231 minutes for ethanol alone, and 389 minutes for the combination, more than additive (PMID 36837798). While animal data cannot be directly extrapolated to humans, the directional finding is consistent with human case data.

What the emergency department data shows

The clinical record is unambiguous. A secondary analysis of the Euro-DEN Plus Registry, 609 GHB/GBL intoxication cases across 22 emergency departments in 14 countries, found that patients who co-ingested alcohol were significantly more likely to experience:

• Reduced consciousness (58.9% vs. 49.1%, p = 0.031)
• ICU admission (55.3% vs. 22.4%, p < 0.001)
• Hospital stay over 6 hours (28.4% vs. 16.9%, p = 0.003)
• Need for active ED treatment (60.4% vs. 49.2%, p = 0.011)

The study’s conclusion: “Co-ingestion of ethanol increases the adverse effects of patients intoxicated by GHB/GBL, leading to greater depression of consciousness, need for treatment, admission to the ICU and longer hospital stay” (PMID 31301370).

A Swiss emergency department case series (78 intoxications, 2002–2015) found coma rates of 77% in alcohol co-users vs. 62% in GHB-only cases, and median recovery times of 142 minutes with alcohol compared to 89 minutes without (PMID 27581664).

An ambulance-attended overdose study recorded 1,112 GHB/GBL poisonings; 59.5% of patients arrived unconscious (GCS 3–7) and 25.4% had reduced consciousness. Overdoses peaked at 1:00 AM, with 40%+ occurring between 10 PM and 4 AM, the rave window (PMID 28938889). Approximately 76% of GHB-related emergency department visits involve concurrent alcohol or other drug use.

The rave-specific trap: drinking to fill the gap

At raves and festivals, GHB is almost always taken in repeated doses across a night. The drug’s short duration, effects last roughly 2–4 hours, means people typically redose 2–3 times. The gap between doses is where alcohol becomes especially dangerous.

Here’s the pattern: someone takes their first dose of GHB, it starts wearing off after an hour or two, and rather than wait for the next dose they have a few drinks to fill the time. They feel fine, maybe a little residual G in the system, alcohol starting to work, but manageable. Then they take their second GHB dose.

The problem is that GHB’s elimination is capacity-limited and slower than most people expect, and alcohol co-administration slows it further. The next GHB dose doesn’t arrive in a cleared system. It stacks on top of residual drug plus active alcohol. The result can be unconsciousness within minutes of the second dose.

DanceSafe’s harm reduction guidance is explicit: “Combining G with alcohol, opioids, benzos, or any other depressant is very dangerous and can be fatal, even if taken several hours apart.” The key phrase is several hours apart, the danger doesn’t require simultaneous ingestion. Alcohol consumed during the gap between GHB doses can still be substantially active when the next dose hits.

GHB overdose: what it looks like and what to do

GHB overdose presents differently from alcohol overdose or opiate overdose. The transition can be shockingly fast, a person who was talking can be unconscious and unresponsive within minutes. Common presentations:

• Sudden loss of consciousness with inability to be roused (the characteristic “G-hole”)
• Vomiting while unconscious: a major aspiration and suffocation risk
• Slow, shallow, or absent breathing
• Muscle limpness, jaw slack
• Cyanosis (blue lips/fingertips) in severe cases
• Seizures (less common, but possible)

In purely GHB overdoses without co-ingestion, recovery is often rapid, sometimes 1–2 hours, with patients waking suddenly and feeling relatively alert. With alcohol co-ingestion, this recovery is significantly prolonged and the overdose is significantly deeper. The patient may not wake for 4–5 hours and is at continued risk throughout.

What to do:

1. Call emergency services immediately: do not wait to “see if they wake up”
2. Place them in the recovery position (on their side, one arm supporting the head) to prevent aspiration if they vomit
3. Do not leave them alone: breathing can stop
4. Monitor breathing: if it stops or becomes extremely slow, be prepared for rescue breathing if trained
5. Tell paramedics exactly what was taken, including alcohol, this directly affects treatment
6. Do not give stimulants (caffeine, cocaine, amphetamines) to “wake them up”, these can cause cardiac arrhythmia in combination with CNS depressants

Many jurisdictions have Good Samaritan laws that protect people who call for help at drug-related emergencies. Call anyway.

The bottom line

GHB and alcohol is a documented, mechanistically understood, clinically confirmed dangerous combination. It is not two drugs that make you “extra drunk.” It is two respiratory depressants with overlapping but distinct mechanisms, combining to produce CNS depression that can kill at doses that neither would cause alone. The narrow therapeutic window of GHB, roughly 2–3x between euphoria and unconsciousness, leaves almost no margin for error when alcohol is also present.

If you use GHB: do not drink alcohol in the same session. If you drink during the gap between doses, the gap is not safe. There is no dose of alcohol that is confirmed harmless in this context.

For a full overview of GHB’s effects, dose guidance, and risks, see our GHB harm reduction guide. For other dangerous combinations, use our interaction checker. For general harm reduction at events, visit our FAQ.

If you’re sourcing GHB and want to verify the contents of an unknown liquid, DanceSafe sells test kits and harm reduction supplies that can help you reduce risk from adulterated substances.

Sources: PMID 36837798 | PMID 31301370 | PMID 27581664 | PMID 28938889 | PMID 26074743 | PMID 16974199